Latest News and Press Releases
Want to stay updated on the latest news?
-
NEWARK, Del:, March 17, 2025 (GLOBE NEWSWIRE) -- The global anti-biofilm wound dressing market is set to witness substantial growth between 2025 and 2035, fueled by the increasing prevalence of...
-
New York, United States, March 03, 2025 (GLOBE NEWSWIRE) -- The global demand for wound care products is increasing as the number of patients with chronic and acute wounds rises. Market leaders...
-
Wound Cleanser Product Market to Surpass US$ 2.24 Billion, Expanding at a 1.4% CAGR by 2034: Fact.MR
Rockville, MD, Sept. 25, 2024 (GLOBE NEWSWIRE) -- According to a new industry report released by Fact.MR, the global wound cleanser product market is estimated at US$ 1.96 billion in 2024 and is...
-
Wilmington, Delaware, United States, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global active wound care market was projected to attain US$ 242.2 million in 2022. It...
-
New York, Aug. 01, 2023 (GLOBE NEWSWIRE) -- The global wound care market size is slated to expand at ~8.4% CAGR between 2023 and 2035. The market is poised to garner a revenue of USD 58 billion by...
-
WASHINGTON, May 04, 2023 (GLOBE NEWSWIRE) -- Global Anti-Biofilm Wound Dressing Market is valued at USD 710.5 Million in 2022 and is projected to reach a value of USD 1315.59 Million by 2030 at a...
-
FRAMINGHAM, Mass., April 25, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
-
New York, Feb. 14, 2023 (GLOBE NEWSWIRE) -- As per Persistence Market Research, the global Wound Healing Ointment Market was valued at US$ 958.1 million in 2021 and is projected to expand at a CAGR...
-
NEWARK, Del, Jan. 23, 2023 (GLOBE NEWSWIRE) -- The net worth of the market share of the anti-biofilm wound dressing is predicted to reach from US$ 782.60 million in 2023 to over US$ 1939.45...
-
FRAMINGHAM, Mass., Sept. 23, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...